the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�
.
.
.
of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met.
.
.
.
.